Ernexa Therapeutics (ERNA) vs 60 Degrees Pharmaceuticals (SXTP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Ernexa Therapeutics is the larger company by market cap ($3.9 million vs $3.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ERNA | SXTP |
|---|---|---|
| Share price | $2.39 | $1.10 |
| Market cap | $3.90M | $3.87M |
| 1-day change | +6.94% | -0.90% |
| EPS (TTM) | $-14.03 | $-5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $71.50 | $8.62 |
| 52-week low | $2.15 | $0.84 |
| Distance from 52-week high | -96.66% | -87.24% |
| Average volume | 462.76K | 129.39K |
| Shares outstanding | 1.63M | 3.52M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ERNA vs SXTP FAQ
Which is bigger, Ernexa Therapeutics or 60 Degrees Pharmaceuticals?
Ernexa Therapeutics (ERNA) is larger, with a market capitalization of $3.90M compared with $3.87M for 60 Degrees Pharmaceuticals (SXTP).
Are Ernexa Therapeutics and 60 Degrees Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.